Archives of Dermatological Research

, Volume 287, Issue 1, pp 48–52 | Cite as

Treatment of severe atopic dermatitis with extracorporeal photopheresis

  • B. Prinz
  • F. Nachbar
  • G. Plewig
Original Paper


Extracorporeal photopheresis using UVA irradiation of enriched lymphocytes in the presence of 8-methoxypsoralen (8-MOP) as a photoactivatable substrate has been employed for the treatment of several immunologically mediated disorders. We report on the first three patients subjected to extracorporeal photopheresis for severe atopic dermatitis. All patients had a lifelong history of atopic skin inflammation, and their disease had finally become resistant to well-established therapeutic regimes. Extracorporeal photopheresis resulted in a marked clinical improvement in the skin lesions of all patients. The decrease in cutaneous inflammatory activity became evident by the end of the second photopheresis cycle. In two patients skin lesions had virtually disappeared after the fifth treatment cycle, while in the third patient a lasting and substantial improvement in pruritus and erythema was achieved. Clinical remission was stable under maintenance therapy with prolonged intervals between photopheresis sessions. Therapeutic efficacy was reflected by a marked reduction in IgE serum levels in all three patients, while serum concentration of IgG, IgM and IgA as well as the profile of circulating lymphocytes remained essentially unchanged. No clinical signs of immunosuppression or other severe adverse events became evident. Collectively, our preliminary results indicate that extracorporeal photopheresis may interfere with the pathomechanisms leading to atopic dermatitis and therefore should be considered as a treatment modality for severe forms of this recalcitrant disorder.

Key words

Atopic dermatitis Extracorporeal photopheresis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Berger CL, Perez M, Laroche L et al (1990) Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol 94: 52–57Google Scholar
  2. 2.
    Bos JD, Wierenga EA, Smitt HS et al (1992) Immune dysregulation in atopic eczema. Arch Dermatol 128: 1509–1512Google Scholar
  3. 3.
    Edelson R, Berger C, Gasparro F et al (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 316: 297–303Google Scholar
  4. 4.
    Gollnick HP, Owsianowski M, Tannenbaum L, et al (1993) Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 28: 122–124Google Scholar
  5. 5.
    Hanifin JM, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92: 44–47Google Scholar
  6. 6.
    Knobler R, Graninger WI, Graninger Wo et al (1992) Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum 35: 319–324Google Scholar
  7. 7.
    Lever R, Turbitt M, Sanderson A et al (1987) Immunophenotyping of the cutaneous infiltrate and of the mononuclear cells in the peripheral blood in patients with atopic dermatitis. J Invest Dermatol 89: 4–7Google Scholar
  8. 8.
    Meneghini CL, Bonifazi E (1985) Correlation between clinical and immunological findings in atopic dermatitits. Acta Derm Venereol Suppl (Stockh) 144: 140–142Google Scholar
  9. 9.
    Ogawa M, Berger PA, McIntyre OR et al (1973) IgE in atopic dermatitis. Arch Dermatol 107: 712–715Google Scholar
  10. 10.
    Perez M, Edelson R, Laroche L et al (1989) Inhibition of anti-skin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol 92: 669–676Google Scholar
  11. 11.
    Rook A, Jegasothy B, Heald P et al (1990) Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 112: 303–305Google Scholar
  12. 12.
    Rook AH, Freundlich B, Jegasothy BV et al (1992) Treatment of systemic sclerosis with extracorporeal photochemotherapy. Arch Dermatol 128: 337–346Google Scholar
  13. 13.
    Stone SP, Muller SA, Gleich GJ (1973) IgE levels in atopic dermatitis. Arch Dermatol 108: 806–811Google Scholar
  14. 14.
    Strannegard ö, Strannegard IL (1991) Changes in cell mediated immunity in atopic eczema In: Ruzicka T, Ring J, Przy-billa B (eds) Handbook of atopic eczema. Springer, Berlin, Heidelberg New York, pp 221–231Google Scholar
  15. 15.
    Thomas P, Senner H, Rieber P et al (1989) In vitro IgE secretion in atopic eczema: influence of allergens and mitogens and role of CD8 T cell subpopulation. Acta Derm Vernereol Suppl (Stockh) 144: 110–114Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • B. Prinz
    • 1
  • F. Nachbar
    • 1
  • G. Plewig
    • 1
  1. 1.Department of DermatologyLudwig Maximilians-University of MunichMunichGermany

Personalised recommendations